Tumor-targetable magnetoluminescent silica nanoparticles for bimodal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo

Bo Song,Qi Liu,Hua Ma,Zhixin Tang,Chaolong Liu,Jinhua Zou,Mingqian Tan,Jingli Yuan
DOI: https://doi.org/10.1016/j.talanta.2020.121378
IF: 6.1
2020-12-01
Talanta
Abstract:<p>Bimodal photoluminescence-magnetic resonance (MR) imaging technique has attracted tremendous attention due to its great potential in biomedical researches and clinical practices. Herein a novel multifunctional magnetoluminescent nanocomposite, <sub>2</sub>, was found to serve as an effective probe for bimodal time-gated luminescence/MR imaging of cancer cells <em>in vitro</em> and <em>in vivo</em>. The nanoprobe was designed by integrating a luminescent Tb<sup>3+</sup> complex, a Gd(III)-based contrast agent and a tumor-targeting molecule, folic acid (FA), into a silica nanoparticle. The integration of these functional moieties allows the nanoprobe to be employed for specific imaging of cancer cells with background-free TGL and non-invasive MR imaging modes. In addition, the optical and magnetic properties were dramatically improved after implicating the newly synthesized nanoarchitecture. In vitro cellular TGL imaging demonstrated that the <sub>2</sub> nanoprobe could recognize and accumulate in cancer cells overexpressing FA receptor. Furthermore, <em>in vivo</em> study revealed that the as-prepared nanoprobe was able to effectively enhance T<sub>1</sub>-weighted MR contrast and TGL intensity in tumor tissue, which might contribute to the precise detection and tracing of cancer cells, as well as diagnosis and therapy of tumor in clinical.</p>
chemistry, analytical
What problem does this paper attempt to address?